Industry News
Pharmaceutical Industry News
Why Casey Left Substack, Elon Musk and Drugs, and an A.I. Antibiotic Discovery
It’s a drug episode.
The Billionaires Spending a Fortune to Lure Scientists Away From Universities
Arena BioWorks is promising big paydays to nearly 100 researchers from Harvard, M.I.T. and other prestigious institutions.
Donald Trump and the 14th Amendment
Responses to four columnists’ discussions about keeping the former president off the ballot. Also: Running mate choices; joy and sorrow; drug overdoses.
Should You Take Paxlovid? What to Know About the Covid Treatment
We asked experts about who should take the antiviral medication, how well it works and where to get it for free.
Use of ADHD Drugs Surged During Pandemic, Study Finds
Social media influencers and online marketing may have played a role, experts said.
An Ultrasound Experiment Tackles a Giant Problem in Brain Medicine
The effects of drugs that treat Alzheimer’s, cancer and other illnesses are often limited by the blood-brain barrier. A small study suggests a way forward.
Pastillas para dormir: una guía de remedios contra el insomnio
¿Antihistamínicos, benzodiacepinas, melatonina? Los expertos recuerdan que el camino más seguro para combatir el insomnio es consultar con el médico.
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.
Singulair, now a generic, is still used by millions of people in the United States even after thousands of patients and dozens of studies have described harm.
El Paxlovid reduce el riesgo de muerte por covid, pero no todos los que lo necesitan lo toman
Al aumentar las muertes por covid, los investigadores se preguntan por qué en EE. UU. el uso del medicamento ha seguido siendo bajo entre los pacientes de alto riesgo.
Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth
The maker of Zepbound and Mounjaro launched a new platform to connect patients and prescribers.
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canada
The agency authorized Florida to purchase medicines directly from wholesalers in Canada, where prices are far cheaper. Pharmaceutical companies oppose the plan.
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.
With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.
Millions Die of Malaria With Miracle Drugs at Hand
Vaccines are available and could be widely distributed if governments paid for them.
Sidney M. Wolfe, Scourge of the Pharmaceutical Industry, Dies at 86
For over 40 years, he and his organization, the Health Research Group, held government and manufacturers to account for unsafe medication.
Resistencia a los antibióticos: lo que hay que saber
Se calcula que el 28 por ciento de los antibióticos recetados a niños y adultos son innecesarios. En esta temporada, aprende cómo usarlos (y cuándo es mejor evitarlos).
A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicine
An A.L.S. drug rejected by the F.D.A. made me rethink how doctors should give hope to patients.
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research
In a wide-ranging interview, Dr. Monica M. Bertagnolli, the director of the National Institutes of Health, discussed drug patents, trust in science and her own experience as a cancer patient.
We Need to Rethink Our Treatment of Pain
Cutting off access to pain medication will only hurt people who are truly suffering.
As Chain Pharmacies Close, Mom-and-Pops Pick Up the Slack
Some small independent pharmacies in the city are benefiting from a decline in chain stores. But theft and low reimbursement rates are still making life hard.
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.